Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-12-2012 | Research

Quantitative detection of Pf HRP2 in saliva of malaria patients in the Philippines

Authors: Andrew O Fung, Robert Damoiseaux, Sarah Grundeen, Jonnas L Panes, Daniel H Horton, Jack W Judy, Theodore B Moore

Published in: Malaria Journal | Issue 1/2012

Login to get access

Abstract

Background

Malaria is a global health priority with a heavy burden of fatality and morbidity. Improvements in field diagnostics are needed to support the agenda for malaria elimination. Saliva has shown significant potential for use in non-invasive diagnostics, but the development of off-the-shelf saliva diagnostic kits requires best practices for sample preparation and quantitative insight on the availability of biomarkers and the dynamics of immunoassay in saliva. This pilot study measured the levels of the Pf HRP2 in patient saliva to inform the development of salivary diagnostic tests for malaria.

Methods

Matched samples of blood and saliva were collected between January and May, 2011 from eight patients at Palawan Baptist Hospital in Roxas, Palawan, Philippines. Parasite density was determined from thick-film blood smears. Concentrations of Pf HRP2 in saliva of malaria-positive patients were measured using a custom chemiluminescent ELISA in microtitre plates. Sixteen negative-control patients were enrolled at UCLA. A substantive difference between this protocol and previous related studies was that saliva samples were stabilized with protease inhibitors.

Results

Of the eight patients with microscopically confirmed P. falciparum malaria, seven tested positive for Pf HRP2 in the blood using rapid diagnostic test kits, and all tested positive for Pf HRP2 in saliva. All negative-control samples tested negative for salivary Pf HRP2. On a binary-decision basis, the ELISA agreed with microscopy with 100 % sensitivity and 100 % specificity. Salivary levels of Pf HRP2 ranged from 17 to 1,167 pg/mL in the malaria-positive group.

Conclusion

Saliva is a promising diagnostic fluid for malaria when protein degradation and matrix effects are mitigated. Systematic quantitation of other malaria biomarkers in saliva would identify those with the best clinical relevance and suitability for off-the-shelf diagnostic kits.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization: World Malaria Report 2010. Tech. Rep., WHO 2010. World Health Organization: World Malaria Report 2010. Tech. Rep., WHO 2010.
2.
go back to reference Shiff CJ, Minjas J, Premji Z: The Parasight-F Test-A Simple Rapid Manual Dipstick Test to Detect Plasmodium-Falciparum Infection. Parasitology Today. 1994, 10 (12): 494-495. 10.1016/0169-4758(94)90164-3.CrossRefPubMed Shiff CJ, Minjas J, Premji Z: The Parasight-F Test-A Simple Rapid Manual Dipstick Test to Detect Plasmodium-Falciparum Infection. Parasitology Today. 1994, 10 (12): 494-495. 10.1016/0169-4758(94)90164-3.CrossRefPubMed
3.
go back to reference Nokes DJ, Enquselassie F, Nigatu W, Vyse AJ, Cohen BJ, Brown DWG, Cutts FT: Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organization. 2001, 79 (7): 588-595. Nokes DJ, Enquselassie F, Nigatu W, Vyse AJ, Cohen BJ, Brown DWG, Cutts FT: Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organization. 2001, 79 (7): 588-595.
4.
go back to reference Haeckel R, Hänecke P: Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur J Clin Chem Clin Biochem. 1996, 34 (3): 171-191.PubMed Haeckel R, Hänecke P: Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur J Clin Chem Clin Biochem. 1996, 34 (3): 171-191.PubMed
5.
go back to reference Thieme T, Yoshihara P, Piacentini S, Beller M: Clinical evaluation of oral fluid samples for diagnosis of viral hepatitis. J Clin Microbiol. 1992, 30 (5): 1076-1079.PubMedCentralPubMed Thieme T, Yoshihara P, Piacentini S, Beller M: Clinical evaluation of oral fluid samples for diagnosis of viral hepatitis. J Clin Microbiol. 1992, 30 (5): 1076-1079.PubMedCentralPubMed
6.
go back to reference Formenty P, Leroy EM, Epelboin A, Libama F, Lenzi M, Sudeck H, Yaba P, Allarangar Y, Boumandouki P, Nkounkou VB, Drosten C, Grolla A, Feldmann H, Roth C: Detection of Ebola Virus in Oral Fluid Specimens during Outbreaks of Ebola Virus Hemorrhagic Fever in the Republic of Congo. Clin Infectious Diseases. 2006, 42 (11): 1521-1526. 10.1086/503836.CrossRef Formenty P, Leroy EM, Epelboin A, Libama F, Lenzi M, Sudeck H, Yaba P, Allarangar Y, Boumandouki P, Nkounkou VB, Drosten C, Grolla A, Feldmann H, Roth C: Detection of Ebola Virus in Oral Fluid Specimens during Outbreaks of Ebola Virus Hemorrhagic Fever in the Republic of Congo. Clin Infectious Diseases. 2006, 42 (11): 1521-1526. 10.1086/503836.CrossRef
7.
go back to reference Kaufman E, Lamster IB: The diagnostic applications of saliva - A review. Crit Rev Oral Biol Med. 2002, 13 (2): 197-212. 10.1177/154411130201300209.CrossRefPubMed Kaufman E, Lamster IB: The diagnostic applications of saliva - A review. Crit Rev Oral Biol Med. 2002, 13 (2): 197-212. 10.1177/154411130201300209.CrossRefPubMed
8.
go back to reference Estevez PT, Satoguina J, Nwakanma DC, West S, Conway DJ, Drakeley CJ: Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum. Malaria J. 2011, 10: 104-108. 10.1186/1475-2875-10-104.CrossRef Estevez PT, Satoguina J, Nwakanma DC, West S, Conway DJ, Drakeley CJ: Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum. Malaria J. 2011, 10: 104-108. 10.1186/1475-2875-10-104.CrossRef
9.
go back to reference Wilson NO, Adjei AA, Anderson W, Baidoo S, Stiles JK: Short report: Detection of Plasmodium falciparum histidine-rich protein II in saliva of malaria patients. Am J Trop Med Hyg. 2008, 78 (5): 733-735.PubMedCentralPubMed Wilson NO, Adjei AA, Anderson W, Baidoo S, Stiles JK: Short report: Detection of Plasmodium falciparum histidine-rich protein II in saliva of malaria patients. Am J Trop Med Hyg. 2008, 78 (5): 733-735.PubMedCentralPubMed
10.
go back to reference Gbotosho GO, Happi CT, Folarin O, Keyamo O, Sowunmi A, Oduola AMJ: Rapid Detection of Lactate Dehydrogenase and Genotyping of Plasmodium falciparum in Saliva of Children with Acute Uncomplicated Malaria. Am J Trop Med Hyg. 2010, 83 (3): 496-501. 10.4269/ajtmh.2010.10-0166.PubMedCentralCrossRefPubMed Gbotosho GO, Happi CT, Folarin O, Keyamo O, Sowunmi A, Oduola AMJ: Rapid Detection of Lactate Dehydrogenase and Genotyping of Plasmodium falciparum in Saliva of Children with Acute Uncomplicated Malaria. Am J Trop Med Hyg. 2010, 83 (3): 496-501. 10.4269/ajtmh.2010.10-0166.PubMedCentralCrossRefPubMed
11.
go back to reference Long GL, Winefordner JD: Limit of Detection. Anal Chem. 1983, 55 (7): A712- Long GL, Winefordner JD: Limit of Detection. Anal Chem. 1983, 55 (7): A712-
12.
go back to reference Howard RJ, Uni S, Aikawa M, Aley SB, Leech JH, Lew AM, Wellems TE, Rener J, Taylor DW: Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol. 1986, 103 (4): 1269-1277. 10.1083/jcb.103.4.1269.CrossRefPubMed Howard RJ, Uni S, Aikawa M, Aley SB, Leech JH, Lew AM, Wellems TE, Rener J, Taylor DW: Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol. 1986, 103 (4): 1269-1277. 10.1083/jcb.103.4.1269.CrossRefPubMed
13.
go back to reference Rock EP, Marsh K, Saul AJ, Wellems TE, Taylor DW, Maloy WL, Howard RJ: Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology (London Print). 1987, 95 (2): 209-227.CrossRef Rock EP, Marsh K, Saul AJ, Wellems TE, Taylor DW, Maloy WL, Howard RJ: Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology (London Print). 1987, 95 (2): 209-227.CrossRef
14.
go back to reference Sullivan DJ, Gluzman IY, Goldberg DE: Plasmodium Hemozoin Formation Mediated by Histidine-Rich Proteins. Science. 1996, 271 (5246): 219-222. 10.1126/science.271.5246.219.CrossRefPubMed Sullivan DJ, Gluzman IY, Goldberg DE: Plasmodium Hemozoin Formation Mediated by Histidine-Rich Proteins. Science. 1996, 271 (5246): 219-222. 10.1126/science.271.5246.219.CrossRefPubMed
15.
go back to reference Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, Pitisuttithum P, Smithyman AM, Day NPJ, White NJ: Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg. 2005, 99 (7): 517-524. 10.1016/j.trstmh.2004.11.014.CrossRefPubMed Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, Pitisuttithum P, Smithyman AM, Day NPJ, White NJ: Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg. 2005, 99 (7): 517-524. 10.1016/j.trstmh.2004.11.014.CrossRefPubMed
16.
go back to reference Sherman IW, Eda S, Winograd E: Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infection. 2003, 5 (10): 897-909. 10.1016/S1286-4579(03)00162-X.CrossRefPubMed Sherman IW, Eda S, Winograd E: Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infection. 2003, 5 (10): 897-909. 10.1016/S1286-4579(03)00162-X.CrossRefPubMed
17.
go back to reference Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NPJ: Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2. PLoS Med. 2005, 2 (8): e204-10.1371/journal.pmed.0020204.PubMedCentralCrossRefPubMed Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NPJ: Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2. PLoS Med. 2005, 2 (8): e204-10.1371/journal.pmed.0020204.PubMedCentralCrossRefPubMed
18.
go back to reference Tjitra E, Suprianto S, McBroom J, Currie BJ, Anstey NM: Persistent ICT Malaria P.f/P.v Panmalarial and HRP2 Antigen Reactivity after Treatment of Plasmodium falciparum Malaria Is Associated with Gametocytemia and Results in False-Positive Diagnoses of Plasmodium vivax in Convalescence. J Clin Microbiol. 2001, 39 (3): 1025-1031. 10.1128/JCM.39.3.1025-1031.2001.PubMedCentralCrossRefPubMed Tjitra E, Suprianto S, McBroom J, Currie BJ, Anstey NM: Persistent ICT Malaria P.f/P.v Panmalarial and HRP2 Antigen Reactivity after Treatment of Plasmodium falciparum Malaria Is Associated with Gametocytemia and Results in False-Positive Diagnoses of Plasmodium vivax in Convalescence. J Clin Microbiol. 2001, 39 (3): 1025-1031. 10.1128/JCM.39.3.1025-1031.2001.PubMedCentralCrossRefPubMed
19.
go back to reference Parra ME, Evans CB, Taylor DW: Identification of Plasmodium-Falciparum Histidine-Rich Protein-2 in the Plasma of Humans with Malaria. J Clin Microbiol. 1991, 29 (8): 1629-1634.PubMedCentralPubMed Parra ME, Evans CB, Taylor DW: Identification of Plasmodium-Falciparum Histidine-Rich Protein-2 in the Plasma of Humans with Malaria. J Clin Microbiol. 1991, 29 (8): 1629-1634.PubMedCentralPubMed
20.
go back to reference Kifude CM, Rajasekariah HG, Sullivan J, David J, Stewart VA, Angov E, Martin SK, Diggs CL, Waitumbi JN: Enzyme-Linked Immunosorbent Assay for Detection of Plasmodium falciparum Histidine-Rich Protein 2 in Blood, Plasma, and Serum. Clin Vaccine Immunol. 2008, 15 (6): 1012-1018. 10.1128/CVI.00385-07.PubMedCentralCrossRefPubMed Kifude CM, Rajasekariah HG, Sullivan J, David J, Stewart VA, Angov E, Martin SK, Diggs CL, Waitumbi JN: Enzyme-Linked Immunosorbent Assay for Detection of Plasmodium falciparum Histidine-Rich Protein 2 in Blood, Plasma, and Serum. Clin Vaccine Immunol. 2008, 15 (6): 1012-1018. 10.1128/CVI.00385-07.PubMedCentralCrossRefPubMed
21.
go back to reference Martin SK, Rajasekariah G: Unified parasite lactate dehydrogenase and histidine-rich protein ELISA for quantification of Plasmodium falciparum. Am J Trop Med Hyg. 2009, 80 (4): 516-PubMed Martin SK, Rajasekariah G: Unified parasite lactate dehydrogenase and histidine-rich protein ELISA for quantification of Plasmodium falciparum. Am J Trop Med Hyg. 2009, 80 (4): 516-PubMed
22.
go back to reference Taylor DW, Voller A: The Development and Validation of a Simple Antigen-Detection Elisa for Plasmodium-Falciparum Malaria. Trans R Soc Trop Med Hyg. 1993, 87: 29-31.CrossRefPubMed Taylor DW, Voller A: The Development and Validation of a Simple Antigen-Detection Elisa for Plasmodium-Falciparum Malaria. Trans R Soc Trop Med Hyg. 1993, 87: 29-31.CrossRefPubMed
23.
go back to reference Desakorn V, Silamut K, Angus B, Sahassananda D, Chotivanich K, Suntharasamai P, Simpson J, White NJ: Semi-quantitative measurement of Plasmodium falciparum antigen PfHRP2 in blood and plasma. Trans R Soc Trop Med Hyg. 1997, 91 (4): 479-483. 10.1016/S0035-9203(97)90292-3.CrossRefPubMed Desakorn V, Silamut K, Angus B, Sahassananda D, Chotivanich K, Suntharasamai P, Simpson J, White NJ: Semi-quantitative measurement of Plasmodium falciparum antigen PfHRP2 in blood and plasma. Trans R Soc Trop Med Hyg. 1997, 91 (4): 479-483. 10.1016/S0035-9203(97)90292-3.CrossRefPubMed
24.
go back to reference Baker J, McCarthy J, Gatton M, Kyle D, Belizario V, Luchavez J, Bell D, Cheng Q: Genetic Diversity of Plasmodium falciparum Histidine-Rich Protein 2 (PfHRP2) and Its Effect on the Performance of PfHRP2-Based Rapid Diagnostic Tests. J Infectious Diseases. 2005, 192 (5): 870-877. 10.1086/432010.CrossRef Baker J, McCarthy J, Gatton M, Kyle D, Belizario V, Luchavez J, Bell D, Cheng Q: Genetic Diversity of Plasmodium falciparum Histidine-Rich Protein 2 (PfHRP2) and Its Effect on the Performance of PfHRP2-Based Rapid Diagnostic Tests. J Infectious Diseases. 2005, 192 (5): 870-877. 10.1086/432010.CrossRef
25.
go back to reference Esser D, Alvarez-Llamas G, de Vries MP, Weening D, Vonk RJ, Roelofsen H: Sample Stability and Protein Composition of Saliva: Implications for Its Use as a Diagnostic Fluid. Biomark Insights. 2008, 3: 25-27.PubMedCentralPubMed Esser D, Alvarez-Llamas G, de Vries MP, Weening D, Vonk RJ, Roelofsen H: Sample Stability and Protein Composition of Saliva: Implications for Its Use as a Diagnostic Fluid. Biomark Insights. 2008, 3: 25-27.PubMedCentralPubMed
26.
go back to reference Wild D: The Immunoassay Handbook. 2005, ELSEVIER Ltd., Oxford, UK Wild D: The Immunoassay Handbook. 2005, ELSEVIER Ltd., Oxford, UK
27.
go back to reference Groschl M, Rauh M: Influence of commercial collection devices for saliva on the reliability of salivary steroids analysis. Steroids. 2006, 13-14: 1097-1100.CrossRef Groschl M, Rauh M: Influence of commercial collection devices for saliva on the reliability of salivary steroids analysis. Steroids. 2006, 13-14: 1097-1100.CrossRef
28.
go back to reference Bronstein I, Voyta JC, Thorpe GHG, Kricka LJ, Armstrong G: Chemi-Luminescent Assay of Alkaline-Phosphatase Applied in an Ultrasensitive Enzyme-Immunoassay of Thyrotropin. Clin Chem. 1989, 35 (7): 1441-1446.PubMed Bronstein I, Voyta JC, Thorpe GHG, Kricka LJ, Armstrong G: Chemi-Luminescent Assay of Alkaline-Phosphatase Applied in an Ultrasensitive Enzyme-Immunoassay of Thyrotropin. Clin Chem. 1989, 35 (7): 1441-1446.PubMed
29.
go back to reference Gad SC: ADME and Biopharmaceutical Properties. 2008, John Wiley & Sons, Inc., NJ 07030, USA Gad SC: ADME and Biopharmaceutical Properties. 2008, John Wiley & Sons, Inc., NJ 07030, USA
30.
go back to reference Laloup M, Tilman G, Maes V, Boeck GD, Wallemacq P, Ramaekers J, Samyn N: Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Forensic Sci Int. 2005, 153: 29-37. 10.1016/j.forsciint.2005.04.019.CrossRefPubMed Laloup M, Tilman G, Maes V, Boeck GD, Wallemacq P, Ramaekers J, Samyn N: Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Forensic Sci Int. 2005, 153: 29-37. 10.1016/j.forsciint.2005.04.019.CrossRefPubMed
31.
go back to reference Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, Shepherd A, Wilson P, Dahl CA, Buchsbaum S, Moeller G: Requirements for high impact diagnostics in the developing world. Nature. 2006, 444 (Suppl 1): 73-79.CrossRefPubMed Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, Shepherd A, Wilson P, Dahl CA, Buchsbaum S, Moeller G: Requirements for high impact diagnostics in the developing world. Nature. 2006, 444 (Suppl 1): 73-79.CrossRefPubMed
32.
33.
go back to reference Hosoe H, Kaise T, Ohmori K, Isohama Y, Kai H, Takahama K, Miyata T: Mucolytic and antitussive effects of erdosteine. J Pharm Pharmacol. 1999, 51 (8): 959-966.CrossRefPubMed Hosoe H, Kaise T, Ohmori K, Isohama Y, Kai H, Takahama K, Miyata T: Mucolytic and antitussive effects of erdosteine. J Pharm Pharmacol. 1999, 51 (8): 959-966.CrossRefPubMed
34.
Metadata
Title
Quantitative detection of Pf HRP2 in saliva of malaria patients in the Philippines
Authors
Andrew O Fung
Robert Damoiseaux
Sarah Grundeen
Jonnas L Panes
Daniel H Horton
Jack W Judy
Theodore B Moore
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-175

Other articles of this Issue 1/2012

Malaria Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine